NLSP - NLS Pharmaceutics Ltd. Company Cash Funds

Official company branding of NLS Pharmaceutics Ltd. (NLSP)

Geopolitical tensions and sanctions are hindering the global drug trials of NLS Pharmaceutics AG (NLSP). The company's cash assets demonstrate liquidity dynamics, where 0.00 reflects the current volume of this metric. This supports the brand image within the ADHD and narcolepsy therapy sector, as well as the operations of a compact staff of scientists motivated by stock options in an academic environment free from excessive bureaucracy.

Company Liquid Assets: NLS Pharmaceutics (NLSP) for 07/04/2022 - 10/31/2025

NLS Pharmaceutics AG - analytical breakdowns and key metrics (NLSP)

- stock value and consensus price forecast:
Fundamental valuation:NLS Pharmaceutics Ltd.
Signature product of NLS Pharma

The cash_co indicator tracks the current balance of liquid assets, reacting instantaneously to capital inflows or operating expenses. This metric determines the issuer's solvency and protection against cash flow gaps. For NLS Pharmaceutics AG (NLSP), whose developments are independent of GDP, this resource is critical due to a reliance on venture capital investments. A stable level of funds guarantees the uninterrupted progression of clinical phases. By analyzing the free cash flow chart, an investor assesses the financial resilience of NLS Pharmaceutics AG (NLSP).